EP3719035 - POLYPEPTIDE INCLUDING ANTIGEN-BINDING DOMAIN AND CARRYING SECTION [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 17.02.2023 Database last updated on 02.11.2024 | |
Former | Request for examination was made Status updated on 04.09.2020 | ||
Former | The international publication has been made Status updated on 08.06.2019 | Most recent event Tooltip | 29.03.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states Chugai Seiyaku Kabushiki Kaisha 5-1, Ukima 5-chome Kita-ku Tokyo 115-8543 / JP | [2020/41] | Inventor(s) | 01 /
IGAWA, Tomoyuki c/o CHUGAI SEIYAKU KABUSHIKI KAISHA 135, Komakado 1-chome Gotemba-shi Shizuoka 412-8513 / JP | 02 /
ISHIKAWA, Hiroyuki c/o CHUGAI SEIYAKU KABUSHIKI KAISHA 135, Komakado 1-chome Gotemba-shi Shizuoka 412-8513 / JP | 03 /
HIRONIWA, Naoka c/o CHUGAI SEIYAKU KABUSHIKI KAISHA 135, Komakado 1-chome Gotemba-shi Shizuoka 412-8513 / JP | 04 /
KAWA, Tatsuya c/o CHUGAI SEIYAKU KABUSHIKI KAISHA 135, Komakado 1-chome Gotemba-shi Shizuoka 412-8513 / JP | [2020/41] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [2020/41] | Application number, filing date | 18882684.6 | 28.11.2018 | [2020/41] | WO2018JP43664 | Priority number, date | JP20170227650 | 28.11.2017 Original published format: JP 2017227650 | JP20180103682 | 30.05.2018 Original published format: JP 2018103682 | [2020/41] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019107380 | Date: | 06.06.2019 | Language: | JA | [2019/23] | Type: | A1 Application with search report | No.: | EP3719035 | Date: | 07.10.2020 | Language: | EN | [2020/41] | Search report(s) | International search report - published on: | JP | 06.06.2019 | (Supplementary) European search report - dispatched on: | EP | 02.08.2021 | Classification | IPC: | C07K16/00, A61K39/395, A61K47/62, C07K19/00, C12P21/08, A61P35/00, A61P37/00, C12N15/13, C12N15/62, C07K14/00, C07K16/28, C07K16/30, C07K16/32 | [2021/35] | CPC: |
C07K16/2866 (EP,US);
C07K16/00 (EP,KR);
C07K16/303 (EP,US);
A61P29/00 (KR);
A61P35/00 (EP,KR);
C07K16/005 (EP);
C07K16/28 (EP);
C07K16/2809 (EP,US);
C07K16/32 (EP,US);
C07K16/4208 (EP);
C07K16/4241 (EP);
A61K2039/505 (KR);
A61P37/00 (EP);
C07K2317/22 (EP);
C07K2317/31 (EP,US);
C07K2317/515 (US);
C07K2317/52 (US);
C07K2317/56 (EP);
C07K2317/569 (EP,US);
C07K2317/64 (EP);
C07K2317/76 (EP);
|
Former IPC [2020/41] | C07K16/00, A61K39/395, A61K47/62, C07K19/00, C12P21/08, A61P35/00, A61P37/00, C12N15/13, C12N15/62 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/41] | Title | German: | POLYPEPTID MIT ANTIGEN-BINDENDEM BEREICH UND TRAGENDEM ABSCHNITT | [2020/41] | English: | POLYPEPTIDE INCLUDING ANTIGEN-BINDING DOMAIN AND CARRYING SECTION | [2020/41] | French: | POLYPEPTIDE COMPRENANT UN DOMAINE DE LIAISON À L'ANTIGÈNE ET UNE SECTION DE TRANSPORT | [2020/41] | Entry into regional phase | 26.06.2020 | Translation filed | 26.06.2020 | National basic fee paid | 26.06.2020 | Search fee paid | 26.06.2020 | Designation fee(s) paid | 26.06.2020 | Examination fee paid | Examination procedure | 26.06.2020 | Examination requested [2020/41] | 24.02.2022 | Amendment by applicant (claims and/or description) | 20.02.2023 | Despatch of a communication from the examining division (Time limit: M06) | 25.08.2023 | Reply to a communication from the examining division | 20.09.2023 | Despatch of a communication from the examining division (Time limit: M06) | 27.03.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 26.06.2020 | Renewal fee patent year 03 | 24.11.2021 | Renewal fee patent year 04 | 24.11.2022 | Renewal fee patent year 05 | 24.11.2023 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2015116933 (CYTOMX THERAPEUTICS INC [US]); | [Y]US2016144042 (WILLIAMS JOHN C [US], et al); | [Y]WO2017162587 (HOFFMANN LA ROCHE [CH], et al); | [IP]WO2018097307 (CHUGAI PHARMACEUTICAL CO LTD [JP]); | [IP]WO2018097308 (CHUGAI PHARMACEUTICAL CO LTD [JP]); | [E]WO2019107384 (CHUGAI PHARMACEUTICAL CO LTD [JP]) | International search | [YA]JP2013538204 ; | by applicant | WO9501937 | US6248516 | WO0220565 | WO0232925 | WO03029462 | WO2004044011 | WO2005040229 | WO2008016854 | WO2009025846 | WO2009125825 | WO2010081173 | WO2010115998 | US2011123527 | WO2013128194 | WO2015048329 | WO2015046554 | WO2015046467 | WO2015116933 | WO2015143414 | WO2016014974 | WO2016046778 | WO2016118629 | US2016289324 | US2016311903 | WO2016179257 | WO2016179285 | WO2016179335 | WO2016179003 |